Position in ABBV
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$1,507,431,018
+$44,489,521 QoQ
Shares Held
6,931,036
+8.3% QoQ
Ownership
0.392%
of shares outstanding
% of Portfolio
0.74%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 96%
None 4%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026JANUS HENDERSON GROUP PLC holds $11,353,030,401 across 14 Drug Manufacturers - General names. ABBV ranks #4 (13.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,347,394 | $3,998,602,577 | |
| 2 | AZN |
Astrazeneca PLC
|
11,949,424 | $2,356,665,399 | |
| 3 | JNJ |
Johnson & Johnson
|
7,872,478 | $1,924,348,519 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
6,931,036 | $1,507,431,018 | |
| 5 | AMGN |
Amgen Inc
|
1,107,159 | $389,553,892 | |
| 6 | NVS |
Novartis AG
|
2,275,938 | $347,649,529 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,880,199 | $346,459,135 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,972,639 | $274,926,696 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,507,431,018 | 6,931,036 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $1,462,941,497 | 6,402,650 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,142,346,349 | 4,933,689 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $702,318,141 | 3,783,634 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $779,588,509 | 3,720,831 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $754,522,195 | 4,246,045 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,984,086,693 | 10,047,026 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,964,010,855 | 11,450,623 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,984,570,596 | 10,898,246 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,496,671,124 | 9,657,812 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,422,255,241 | 9,541,495 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,444,744,952 | 10,723,261 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,150,656,074 | 13,494,736 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,508,926,080 | 15,524,572 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,174,718,168 | 16,203,846 | Shares | Defined | 2023-01-13 | |
| 2022-06-30 | $2,493,336,053 | 16,279,290 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,777,287,483 | 17,132,117 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,002,372,513 | 14,788,571 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,774,173,055 | 16,447,326 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $2,008,246,620 | 17,828,894 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,993,690,741 | 18,422,572 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,964,303,587 | 18,332,278 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,486,312,870 | 16,968,979 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,609,030,882 | 16,388,581 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $877,380,344 | 11,515,689 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||